Holistic dementia care reduces staff burdens, enhances provider market position
By
Paul Tanico
Feb 01, 2024
By adopting a comprehensive strategy that balances clinical insights, lifestyle interventions and economic considerations, staff members can unlock the potential for improved outcomes and elevate the facility’s...
You are what you eat: Why nutrition is so important in senior living
By
Melissa Powell
Nov 06, 2023
Nutrition often is underestimated yet holds the key to unlocking a world of health, vitality and happiness for our residents.
Appendicular lean mass linked to decrease in Alzheimer’s risk
Jul 10, 2023
A higher appendicular lean mass also was associated with increased cognitive performance.
Alzheimer’s Association calls for federal involvement to increase dementia care workforce, training...
By
Lois A. Bowers
Jan 29, 2024
“Congress should consider the steps it can take at the federal level, including expanding the necessary workforce and improving dementia training standards and access,” as part of efforts to “help...
RecallCue wins Gold for dementia clock
By
Foster Stubbs
Nov 11, 2022
Gold in the Tech Partner of the Year category of the 2022 McKnight’s Excellence in Technology Awards goes to RecallCue, an internet-connected day clock meant to combat the effects of dementia.
FDA approves first drug meant to ease Alzheimer’s disease-llnked agitation
May 11, 2023
Patients who received 2 or 3 mg of Rexulti had significant improvements in agitation scores compared with patients taking a placebo.
Study IDs proportion of dementia cases attributable to known risk factors
Jan 19, 2024
The population-attributable fraction for nongenetic risk factors combined is similar for men and women, but it varies across racial and ethnic groups.
Dementia costs jump 31 percent in a decade, with care needs expected to grow
By
Alicia Lasek
Nov 02, 2022
Despite progress in risk reduction, testing and treatment, the costs of dementia care in the United States continue to rise alongside dementia prevalence, putting the onus on healthcare providers and other...
Lower Alzheimer’s risk seen with PDE5i initiation for erectile dysfunction
Feb 08, 2024
The greatest reduction in risk was seen for those receiving 21 to 50 phosphodiesterase type 5 inhibitor prescriptions.
5α-reductase inhibitors linked to depression, but not dementia
Dec 29, 2022
The magnitude of association for finasteride and dutasteride with dementia decreased over time and became nonsignificant.